home / stock / htbx / htbx quote
Last: | $2.83 |
---|---|
Change Percent: | -3.74% |
Open: | $2.97 |
Close: | $2.83 |
High: | $3.05 |
Low: | $2.81 |
Volume: | 136,107 |
Last Trade Date Time: | 02/11/2022 04:55:28 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.83 | $2.97 | $2.83 | $3.05 | $2.81 | 136,107 | 02-11-2022 |
$2.94 | $2.86 | $2.94 | $3.04 | $2.86 | 87,339 | 02-10-2022 |
$2.9 | $2.75 | $2.9 | $2.94 | $2.71 | 123,782 | 02-09-2022 |
$2.76 | $2.74 | $2.76 | $2.85 | $2.67 | 104,812 | 02-08-2022 |
$2.78 | $2.75 | $2.78 | $2.87 | $2.75 | 144,666 | 02-07-2022 |
$2.76 | $2.73 | $2.76 | $2.8 | $2.65 | 120,924 | 02-04-2022 |
$2.75 | $2.75 | $2.75 | $2.79 | $2.7 | 116,254 | 02-03-2022 |
$2.78 | $3.03 | $2.78 | $3.03 | $2.75 | 114,348 | 02-02-2022 |
$2.99 | $2.93 | $2.99 | $3.03 | $2.88 | 94,580 | 02-01-2022 |
$2.92 | $2.67 | $2.92 | $2.95 | $2.62 | 194,170 | 01-31-2022 |
$2.63 | $2.55 | $2.63 | $2.63 | $2.45 | 111,240 | 01-28-2022 |
$2.53 | $2.71 | $2.53 | $2.89 | $2.5 | 92,564 | 01-27-2022 |
$2.71 | $2.9 | $2.71 | $2.99 | $2.69 | 154,350 | 01-26-2022 |
$2.73 | $2.6 | $2.73 | $2.8 | $2.6 | 111,215 | 01-25-2022 |
$2.65 | $2.59 | $2.65 | $2.6983 | $2.45 | 261,191 | 01-24-2022 |
$2.71 | $2.83 | $2.71 | $2.8434 | $2.6701 | 223,336 | 01-21-2022 |
$2.84 | $2.88 | $2.84 | $3.0353 | $2.8 | 161,371 | 01-20-2022 |
$2.9 | $2.95 | $2.9 | $2.98 | $2.865 | 174,182 | 01-19-2022 |
$2.97 | $3.01 | $2.97 | $3.1 | $2.93 | 161,493 | 01-18-2022 |
$3.03 | $3.07 | $3.03 | $3.0863 | $2.97 | 255,208 | 01-17-2022 |
News, Short Squeeze, Breakout and More Instantly...
DURHAM, N.C., March 19, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) , an integrated contract development and manufacturing organization (CDMO), today announced that it has been awarded a contract in excess of $1 million with an NIH-funded researcher at a ...
DURHAM, N.C., March 14, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) , an integrated contract development and manufacturing organization (CDMO), today announced that it has been accepted into the Biopharmaceutical Manufacturing Preparedness Consortium (Bio...
DURHAM, N.C., March 12, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc. (NYSE American: SCPX), (“Scorpius” or the “Company”), an integrated contract development and manufacturing organization (CDMO), today announced the closing of its previously announced public offer...